Clinical Research Directory
Browse clinical research sites, groups, and studies.
Safety Registry of a Fecal Microbiota Transplant Cohort
Sponsor: Assistance Publique - Hôpitaux de Paris
Summary
Clostridium difficile infection (CDI) is a major cause of infectious diarrhea and the most important cause of nosocomial diarrhea. Recurrent forms are a major problem with this infection. The use of fecal microbiota transplantation (FMT), FMT appears in the most recent European and North American recommendations. There is no cohort or multicenter registry in France prospectively collecting FMTs, the methods used, their efficacy and side effects. Likewise, there is no prospective collection focused on the cohort of stool donors. A large national cohort of patients who have undergone FMT as part of routine care as well as donors, is essential for evaluating the safety of FMT.
Official title: Safety Registry of a Fecal Microbiota Transplant Cohort (COSMIC-FMT)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
OBSERVATIONAL
Enrollment
305
Start Date
2021-01-04
Completion Date
2029-01-04
Last Updated
2025-06-25
Healthy Volunteers
Yes
Conditions
Locations (1)
Gastroenterology Department of Saint Antoine Hospital
Paris, France